Vanguard Group’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $36.9M | Sell |
|
|||||
|
2022
Q2 | $20.4M | Buy |
|
|||||
|
2022
Q1 | $23.3M | Sell |
|
|||||
|
2021
Q4 | $23.7M | Sell |
|
|||||
|
2021
Q3 | $49.9M | Buy |
|
|||||
|
2021
Q2 | $69.6M | Buy |
|
|||||
|
2021
Q1 | $76M | Buy |
|
|||||
|
2020
Q4 | $57M | Buy |
|
|||||
|
2020
Q3 | $47.5M | Sell |
|
|||||
|
2020
Q2 | $62.9M | Sell |
|
|||||
|
2020
Q1 | $58.6M | Buy |
|
|||||
|
2019
Q4 | $102M | Buy |
|
|||||
|
2019
Q3 | $79.8M | Sell |
|
|||||
|
2019
Q2 | $124M | Buy |
|
|||||
|
2019
Q1 | $195M | Buy |
|
|||||
|
2018
Q4 | $146M | Buy |
|
|||||
|
2018
Q3 | $239M | Buy |
|
|||||
|
2018
Q2 | $233M | Buy |
|
|||||
|
2018
Q1 | $174M | Buy |
|
|||||
|
2017
Q4 | $183M | Buy |
|
|||||
|
2017
Q3 | $146M | Buy |
|
|||||
|
2017
Q2 | $113M | Buy |
|
|||||
|
2017
Q1 | $63.2M | Buy |
|
|||||
|
2016
Q4 | $49.2M | Buy |
|
|||||
|
2016
Q3 | $42.9M | Buy |
|
|||||
|
2016
Q2 | $17.7M | Buy |
|
|||||
|
2016
Q1 | $11M | Buy |
|
|||||
|
2015
Q4 | $20.8M | Buy |
|
|||||
|
2015
Q3 | $12.4M | Buy |
|
|||||
|
2015
Q2 | $10.2M | Buy |
|
|||||
|
2015
Q1 | $17M | Buy |
|
|||||
|
2014
Q4 | $9.55M | Buy |
|
|||||
|
2014
Q3 | $5.48M | Buy |
|
|||||
|
2014
Q2 | $4.79M | Buy |
|
|||||
|
2014
Q1 | $3.46M | Buy |
|
|||||
|
2013
Q4 | $1.65M | Buy |
|